In the News
Latest News:
Pimavanserin Associated With Lower Relapse Risk of DRP, Symptom Reduction
August 05, 2021
NeurologyLive
The State of Alzheimer Disease Clinical Trials and Prevention Efforts: Eric Reiman, MD
August 05, 2021
NeurologyLive
Trial to Test Donanemab in People With Alzheimer’s Signs, Not Symptoms
July 20, 2021
Alzheimer's News Today
Lilly and Banner Alzheimer's Institute collaborate on planned Phase 3 prevention trial of donanemab
July 15, 2021
PR Newswire
Many Alzheimer’s Experts Say Use of Aduhelm Should Be Sharply Limited
June 22, 2021
The New York Times
Alzheimer’s Disease: FDA Rolls Out Prescribing Information for Aducanumab
June 14, 2021